Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013

Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference 
Call on May 3, 2013 
PALATINE, IL -- (Marketwired) -- 04/22/13 --  Acura Pharmaceuticals,
Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating
abuse deterrent drugs, today announced that the company plans to
report financial results for the first quarter of 2013 following the
close of financial markets on Thursday, May 2, 2013. The company will
host a conference call to discuss the results on Friday, May 3, 2013
at 8:30 a.m. ET. 
To participate in the live conference call, please dial 888-427-9419
(U.S. and Canada) five to ten minutes prior to the start of the call.
The participant passcode is 1259095.  
A replay of the call will be available beginning May 6, 2013 at 11:30
a.m. ET and ending on May, 27, 2013 on the company's website, and by
dialing 888-203-1112 (U.S. and Canada). The replay participant code
is 1259095. 
About Acura Pharmaceuticals
 Acura Pharmaceuticals is a specialty
pharmaceutical company engaged in the research, development and
commercialization of product candidates intended to address
medication abuse and misuse, utilizing its proprietary AVERSION(R)
and IMPEDE(TM) technologies. In June 2011, the U.S. Food and Drug
Administration approved OXECTA(R) which incorporates the AVERSION(R)
technology. The Company has a development pipeline of additional
AVERSION(R) technology products including other opioids and its
IMPEDE(TM) technology for pseudoephedrine hydrochloride products. 
The trademark OXECTA(R) is owned by Pfizer Inc. 
Contact:
for Acura Investor Relations
investors@acurapharm.com 
847-705-7709 
for Acura Media Relations
pr@acurapharm.com 
847-705-7709 
 
 
Press spacebar to pause and continue. Press esc to stop.